TheraRadar
Data updated: May 26, 2026

ELIMITE (permethrin)

Infectious Disease Approved 1989-08-25

ELIMITE is indicated for the treatment of Scabies.

Source: FDA Label • Aurobindo Pharma
2
Indications
--
Phase 3 Trials
36
Years on Market

Details

Status
Prescription
First Approved
1989-08-25
Routes
TOPICAL
Dosage Forms
CREAM

Companies

Active Ingredient: PERMETHRIN

ELIMITE Approval History

1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
8 FDA actions from 1989 to 2016 · 1 indication expansions
Feb 2016 SUPPL
Mfg · Manufacturing (CMC)
Dec 2001 SUPPL
Mfg · Manufacturing (CMC)
Jan 2001 SUPPL
Label · Labeling

What ELIMITE Treats

1 indications

ELIMITE is approved for 1 conditions since its original approval in 1989. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Scabies
Source: FDA Label

ELIMITE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Indication competitors

1

Same indication, different mechanism — what else might this patient receive?

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to ELIMITE

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

CROTAN
CROTAMITON
1 shared
LEGACY PHARMA
Shared indications:
Scabies
PERMETHRIN
PERMETHRIN
1 shared
PERRIGO NEW YORK
Shared indications:
Scabies
📋

Clinical Trial Registry

5 trials
Trial Sponsor ID Phase Status Title
NCT02407782 SCRATCH CHUBX 2011/16 Ph 3 completed Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults
NCT05862701 CMH Abbottabad Dermatology Ph 1 completed Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of Scabies
NCT02978508 results posted MAP-8184 Ph 3 completed Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.
NCT02775617 AIM-Skin results posted 35148A Ph 4 completed Azithromycin - Ivermectin Mass Drug Administration for Skin Disease
NCT02572986 DRL-USG02-P/2015 Ph 3 completed A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

ELIMITE FDA Label Details

Indications & Usage

ELIMITE is indicated for the treatment of Scabies.

Track ELIMITE with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.